No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BSX250117C98000
- 0.15
- -0.06-28.57%
15min DelayClose Jan 14 16:00 ET
0.25High0.15Low
0.25Open0.21Pre Close38 Volume131 Open Interest98.00Strike Price715.00Turnover25.76%IV2.61%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.1408Delta0.1060Gamma637.67Leverage Ratio-0.0856Theta0.0010Rho89.81Eff Leverage0.0183Vega
Intraday
- 5D
- Daily
News
CardioFocus Announces Publication of 1-Year ECLIPSE AF Clinical Trial Results
Boston Scientific Expects Farapulse, Watchman to Drive 2025 Growth
Citi Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $107
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
Why Boston Scientific (BSX) Is Skyrocketing in 2025?
Baird Adjusts Price Target on Boston Scientific $104 From $102, Keeps Outperform Rating